Sido Muncul Overview

  • Year Founded
  • 1951

Year Founded

  • Status
  • Public

  • Employees
  • 3,589

Employees

  • Stock Symbol
  • SIDO

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.04
  • (As of Friday Closing)

Sido Muncul General Information

Description

PT Industri Jamu dan Farmasi Sido Muncul Tbk is biotechnology company that provides herbal medicine and pharmaceutical products. The company has three business segments, Herbal Medicine, Food and Beverage, and Pharmacy. The Herbal Medicine segment provides herbal supplements, while its Food and Beverage segment sells packaged foods, soft drinks, and candy and confectionary products. The Pharmacy segment sells pharmaceutical products such as Anacetine, a fever reducer, Berlosid, a medicine to reduce gastric pain, and Combicitrine, a medicine for bacterial removal. The company generates the majority of its revenue in Indonesia.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Tentrem Hotel Building Jalan Legian Gajahmada No. 123
  • 1st Floor
  • Semarang, 50134
  • Indonesia
+62 (024)
Primary Industry
Pharmaceuticals
Other Industries
Personal Products
Food Products
Stock Exchange
IDX
Vertical(s)
LOHAS & Wellness, Manufacturing, Life Sciences
Corporate Office
  • Tentrem Hotel Building Jalan Legian Gajahmada No. 123
  • 1st Floor
  • Semarang, 50134
  • Indonesia
+62 (024)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sido Muncul Stock Performance

As of 14-Feb-2025, Sido Muncul’s stock price is $0.04. Its current market cap is $1.15B with 30B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.04 $0.04 $0.03 - $0.05 $1.15B 30B 14.5M

Sido Muncul Financials Summary

As of 30-Sep-2024, Sido Muncul has a trailing 12-month revenue of $242M.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 1,274,823 958,685 1,392,855 1,744,086
Revenue 242,044 233,743 260,022 279,977
EBITDA 96,624 84,850 100,117 116,316
Net Income 72,158 62,314 74,311 87,795
Total Assets 260,652 249,165 262,339 284,567
Total Debt 218 601 153 606
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sido Muncul Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sido Muncul‘s full profile, request access.

Request a free trial

Sido Muncul Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sido Muncul Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sido Muncul‘s full profile, request access.

Request a free trial

Sido Muncul Acquisitions (1)

Sido Muncul’s most recent deal was a Merger/Acquisition with PT. Berlico Mulia Farma. The deal was made on 01-Sep-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PT. Berlico Mulia Farma 01-Sep-2014 Merger/Acquisition Pharmaceuticals
To view Sido Muncul’s complete acquisitions history, request access »

Sido Muncul ESG

Risk Overview

Risk Rating

Updated January, 28, 2025

21.68 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,120

Rank

Percentile

Pharmaceuticals

Industry

of 853

Rank

Percentile

Pharmaceuticals

Subindustry

of 425

Rank

Percentile

To view Sido Muncul’s complete esg history, request access »

Sido Muncul FAQs

  • When was Sido Muncul founded?

    Sido Muncul was founded in 1951.

  • Where is Sido Muncul headquartered?

    Sido Muncul is headquartered in Semarang, Indonesia.

  • What is the size of Sido Muncul?

    Sido Muncul has 3,589 total employees.

  • What industry is Sido Muncul in?

    Sido Muncul’s primary industry is Pharmaceuticals.

  • Is Sido Muncul a private or public company?

    Sido Muncul is a Public company.

  • What is Sido Muncul’s stock symbol?

    The ticker symbol for Sido Muncul is SIDO.

  • What is the current stock price of Sido Muncul?

    As of 14-Feb-2025 the stock price of Sido Muncul is $0.04.

  • What is the current market cap of Sido Muncul?

    The current market capitalization of Sido Muncul is $1.15B.

  • What is Sido Muncul’s current revenue?

    The trailing twelve month revenue for Sido Muncul is $242M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »